Sign in to view content

Effects of the Mitochondria-Targeted Drug Elamipretide on Leakage-Independent Vision Loss in Fellow Eyes with Neovascular AMD in the ReCLAIM Study

Priyatham (Prithu) S Mettu, MD

Video
Published 2019

Related

Episode 162: April 2019 Retinal Physician Preview Discussion of AMD Topics with Dr. Margaret Greven and Dr. M. Ali Khan
Jayanth Sridhar, MD
Member Podcasts
2018
Dexamethasone Intracameral Drug-Delivery Suspension for Inflammation Associated With Vitreoretinal Surgery
Daniel F. Kiernan, MD, FACS
Annual Meeting Talks
2020
Ten-Year Follow-up Data From the AREDS2 Study
Emily Y. Chew, MD
Updates from the Field
2021

Category: AMD-Non-Neovascular

See more